Endothelial-derived EVs | |
---|---|
Cargo | Role |
miR-10a, 19a, 23b, 101, 143, and 145 | Suppress NF-kB, limit atherosclerotic plaque |
miR-126 and miR-181b | Reduce monocyte activation |
miR-146a | Reduces cardiac contractile function |
A2 AR | Hyperhomocysteinemia in CAD |
miR-126-5p | Reduces endothelial dysfunction, improves cardiac function in HF |
miR-1, miR-30, miR-133a, miR-208, miR-499 | More sensible than hs-TnI in AMI |
miR-499-5p | Superior to hs-cTnT in NSTEMI vs acute HF |
miR-208a | Correlates with severity and mortality in AMI |
miR-192, miR-194 and miR-34a | Correlate with LVEDD in AMI |
miR-423-3p | Reduces cell apoptosis in IRI |
miR-214 | Prevents calcium overload |
miR- 155 | Inflammatory macrophage polarization |
miR-29b and miR-455 | Antifibrotic |
miR-712 and miR-205 | Enhance endothelial inflammation |
HSP70, Arginase-1 | Endothelial dysfunction |
miR-122 and miR-192 | Obesity and insulin resistance |
miR-29a | Obesity, correlates with NT-proBNP |
miR-410-5p | Cardiac fibrosis |
miR-132 and miR-17-5p | Inverse correlation with BMI |
miR-423-5p, miR-520c-3p and miR-15a | Morbid obesity and metabolic syndrome |
miR-483 | Insulin resistance, dyslipidemia, obesity, risk of developing T2DM |
miR-21 | Reduced in T2DM and metabolic syndrome |
IgG | Retinal damage in T2DM |
TGF-β1 | Apoptosis in renal glomerular cells |